Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050)
China flag China · Delayed Price · Currency is CNY
91.79
-0.50 (-0.54%)
Nov 19, 2024, 3:00 PM CST

Eyebright Medical Technology (Beijing) Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
17,45118,10724,26422,10318,187-
Upgrade
Market Cap Growth
-0.46%-25.37%9.78%21.53%--
Upgrade
Enterprise Value
17,82217,74724,23221,76917,754-
Upgrade
Last Close Price
92.0795.26127.45115.9495.31-
Upgrade
PE Ratio
47.2559.57104.27129.00188.35-
Upgrade
Forward PE
30.1946.1681.03105.28140.78-
Upgrade
PS Ratio
12.8119.0441.8751.0466.61-
Upgrade
PB Ratio
7.497.6912.6412.7011.75-
Upgrade
P/TBV Ratio
9.389.9314.0114.1612.74-
Upgrade
P/FCF Ratio
----3933.10-
Upgrade
P/OCF Ratio
63.0385.1697.00100.79147.44-
Upgrade
PEG Ratio
1.311.311.94---
Upgrade
EV/Sales Ratio
13.1218.6641.8250.2765.02-
Upgrade
EV/EBITDA Ratio
34.8846.7989.28115.75143.49-
Upgrade
EV/EBIT Ratio
43.2657.59104.62137.88182.91-
Upgrade
EV/FCF Ratio
-102.98---3839.48-
Upgrade
Debt / Equity Ratio
0.250.180.080.09--
Upgrade
Debt / EBITDA Ratio
1.231.090.590.82--
Upgrade
Asset Turnover
0.460.360.270.230.230.31
Upgrade
Inventory Turnover
2.321.741.311.180.730.57
Upgrade
Quick Ratio
3.472.056.397.3713.8311.05
Upgrade
Current Ratio
4.762.717.198.0214.8714.47
Upgrade
Return on Equity (ROE)
14.76%13.38%12.42%10.20%8.76%10.95%
Upgrade
Return on Assets (ROA)
8.72%7.26%6.75%5.35%5.22%5.91%
Upgrade
Return on Capital (ROIC)
9.38%7.93%7.28%5.73%5.53%6.21%
Upgrade
Earnings Yield
2.12%1.68%0.96%0.78%0.53%-
Upgrade
FCF Yield
-0.99%-0.87%-0.09%-0.42%0.03%-
Upgrade
Dividend Yield
0.29%0.29%0.22%0.18%0.16%-
Upgrade
Payout Ratio
18.75%20.19%19.10%17.81%--
Upgrade
Buyback Yield / Dilution
-0.02%-0.25%-0.17%-17.57%-13.96%-8.20%
Upgrade
Total Shareholder Return
0.28%0.04%0.06%-17.39%-13.79%-8.20%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.